These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 32274759)
1. The Interplay Between Proteostasis Systems and Parkinson's Disease. Lázaro DF; Outeiro TF Adv Exp Med Biol; 2020; 1233():223-236. PubMed ID: 32274759 [TBL] [Abstract][Full Text] [Related]
2. Protein trapping leads to altered synaptic proteostasis in synucleinopathies. Santos PI; Outeiro TF FEBS J; 2020 Dec; 287(24):5294-5303. PubMed ID: 32400966 [TBL] [Abstract][Full Text] [Related]
3. Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies. Schildknecht S; Gerding HR; Karreman C; Drescher M; Lashuel HA; Outeiro TF; Di Monte DA; Leist M J Neurochem; 2013 May; 125(4):491-511. PubMed ID: 23452040 [TBL] [Abstract][Full Text] [Related]
4. Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking. Stojkovska I; Wani WY; Zunke F; Belur NR; Pavlenko EA; Mwenda N; Sharma K; Francelle L; Mazzulli JR Neuron; 2022 Feb; 110(3):436-451.e11. PubMed ID: 34793693 [TBL] [Abstract][Full Text] [Related]
5. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies. Brás IC; Outeiro TF Cells; 2021 Feb; 10(2):. PubMed ID: 33673034 [TBL] [Abstract][Full Text] [Related]
6. Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in α-Synuclein Aggregation Disorders. Ugras S; Daniels MJ; Fazelinia H; Gould NS; Yocum AK; Luk KC; Luna E; Ding H; McKennan C; Seeholzer S; Martinez D; Evans P; Brown D; Duda JE; Ischiropoulos H EBioMedicine; 2018 May; 31():307-319. PubMed ID: 29759483 [TBL] [Abstract][Full Text] [Related]
7. Nrf2 mitigates LRRK2- and α-synuclein-induced neurodegeneration by modulating proteostasis. Skibinski G; Hwang V; Ando DM; Daub A; Lee AK; Ravisankar A; Modan S; Finucane MM; Shaby BA; Finkbeiner S Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1165-1170. PubMed ID: 28028237 [TBL] [Abstract][Full Text] [Related]
9. Traffic jams and the complex role of α-Synuclein aggregation in Parkinson disease. Gonçalves SA; Outeiro TF Small GTPases; 2017 Apr; 8(2):78-84. PubMed ID: 27314512 [TBL] [Abstract][Full Text] [Related]
10. The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation. Lázaro DF; Dias MC; Carija A; Navarro S; Madaleno CS; Tenreiro S; Ventura S; Outeiro TF Acta Neuropathol Commun; 2016 Dec; 4(1):128. PubMed ID: 27938414 [TBL] [Abstract][Full Text] [Related]
11. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease. Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782 [TBL] [Abstract][Full Text] [Related]
12. Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease. Bobela W; Aebischer P; Schneider BL Biomolecules; 2015 Oct; 5(4):2675-700. PubMed ID: 26501339 [TBL] [Abstract][Full Text] [Related]
13. Broad proteomics analysis of seeding-induced aggregation of α-synuclein in M83 neurons reveals remodeling of proteostasis mechanisms that might contribute to Parkinson's disease pathogenesis. Lumpkin CJ; Patel H; Potts GK; Chaurasia S; Gibilisco L; Srivastava GP; Lee JY; Brown NJ; Amarante P; Williams JD; Karran E; Townsend M; Woods D; Ravikumar B Mol Brain; 2024 May; 17(1):26. PubMed ID: 38778381 [TBL] [Abstract][Full Text] [Related]
14. Molecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other synucleinopathies. Ebrahimi-Fakhari D; Saidi LJ; Wahlster L Acta Neuropathol Commun; 2013 Dec; 1(1):79. PubMed ID: 24314025 [TBL] [Abstract][Full Text] [Related]
15. Alpha-Synuclein and GM1 Ganglioside Co-Localize in Neuronal Cytosol Leading to Inverse Interaction-Relevance to Parkinson's Disease. Kumar R; Chowdhury S; Ledeen R Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542297 [TBL] [Abstract][Full Text] [Related]